{
    "Trade/Device Name(s)": [
        "STA - NeoPTimal",
        "STA\u00ae - NeoPTimal 5",
        "STA\u00ae - NeoPTimal 10"
    ],
    "Submitter Information": "Diagnostica Stago, Inc.",
    "510(k) Number": "K211485",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003870"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "September 2, 2022",
    "Summary Letter Received Date": "September 6, 2022",
    "Submission Date": "May 12, 2021",
    "Regulation Number(s)": [
        "21 CFR 864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)",
        "Factor II (prothrombin)",
        "Factor V (proaccelerin)",
        "Factor VII (proconvertin)",
        "Factor X (Stuart factor)",
        "Factor I (fibrinogen)",
        "INR (International Normalized Ratio)"
    ],
    "Specimen Type(s)": [
        "Human citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "STA-R family",
        "STA Compact family",
        "STA Satellite family"
    ],
    "Method(s)/Technology(ies)": [
        "Clotting time measurement",
        "Calcium thromboplastin assay"
    ],
    "Methodologies": [
        "One-stage clotting assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for STA - NeoPTimal prothrombin time reagent kit for quantitative determination of PT/INR on STA analyzers",
    "Indications for Use Summary": "Quantitative determination of Prothrombin Time (PT) in human citrated plasma on STA analyzer families, to evaluate the extrinsic coagulation pathway and monitor oral vitamin K antagonist therapy using INR.",
    "fda_folder": "Hematology"
}